Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Series A Non-Voting Convertible Preferred Stock
Preferred Stock
Series A-1 Non-Voting Convertible Preferred Stock
Common Stock
Registered Direct Offering
Common Stock
Additional Paid-In Capital
Registered Direct Offering
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Registered Direct Offering
Total
Balances, Beginning at Dec. 31, 2024 $ 74,405,362                    
Balances, Beginning (in Shares) at Dec. 31, 2024 2,213.8044                    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock $ 1,256,662                   $ (1,256,662)
Balances, Ending at Mar. 31, 2025 $ 75,662,024 $ 24,994,461                  
Balances, Ending (in Shares) at Mar. 31, 2025 2,213.8044 284.2638                  
Balances, Beginning at Dec. 31, 2024       $ 133   $ 67,856,589 $ (73,818,946) $ (3,862,987) $ (299,128)   (10,124,339)
Balances, Beginning (in shares) at Dec. 31, 2024       1,332,178              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Conversion of loan payable plus interest into Series A-1 NonVoting Convertible Preferred Stock   $ 24,994,461                 24,994,461
Conversion of loan payable plus interest into Series A-1 NonVoting Convertible Preferred Stock (in shares)   284.2638                  
Proceeds from issuance of common stock, net of fees     $ 58   $ 4,252,735         $ 4,252,793  
Proceeds from issuance of common stock, net of fees (in shares)     578,950                
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock           (1,256,662)         (1,256,662)
Share-based compensation expense           84,474         84,474
Net loss             (10,924,952)       (10,924,952)
Foreign currency translation adjustment               61,156     61,156
Balances, Ending at Mar. 31, 2025       $ 191   70,937,136 (84,743,898) (3,801,831) (299,128)   $ 7,086,931
Balances, Ending (in shares) at Mar. 31, 2025       1,911,128              
Balances, Beginning (in Shares) at Dec. 31, 2025                     0
Balances, Ending (in Shares) at Mar. 31, 2026                     0
Balances, Beginning at Dec. 31, 2025       $ 2,974   183,856,376 (108,076,316) (587,039) (299,128)   $ 74,896,867
Balances, Beginning (in shares) at Dec. 31, 2025       29,743,516              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Conversion of loan payable plus interest into Series A-1 NonVoting Convertible Preferred Stock           11,397,225         11,397,459
Proceeds from issuance of common stock, net of fees       $ 234              
Proceeds from issuance of common stock, net of fees (in shares)       2,338,948              
Proceeds from issuance of prefunded warrants       $ 132             132
Proceeds from issuance of prefunded warrants (in shares)       1,319,089              
Share-based compensation expense           449,419         449,419
Net loss             (4,986,614)       (4,986,614)
Foreign currency translation adjustment               (1,133,911)     (1,133,911)
Balances, Ending at Mar. 31, 2026       $ 3,340   $ 195,703,020 $ (113,062,930) $ (1,720,950) $ (299,128)   $ 80,623,352
Balances, Ending (in shares) at Mar. 31, 2026       33,401,553